Abstract
RCC is one of the main problems in oncourology. MiRNA expression profiles are highly specific for malignant tumors of different locations, and can be used to detect pathological molecular biomarkers and to develop the optimal treatment for each patient. Selection of miRNAs associated with the formation and development of malignant tumors in the kidney was performed using computer databases miRWalk ( http://www.ma.uni-hei-delberg.de/apps/zmf/mirwalk/ ) and miRBase ( http://www.mir-base.org/ ). Paired samples of tumor and histologically normal tissue from 46 patients with RCC were studied. RNA was isolated by phenol–chloroform extraction and treated with RNase-free DNase after isolation. MiRNA expression analysis was performed by RT-qPCR using Applied Biosystems (USA) kits: TaqMan® MicroRNA Assays, TaqMan® MicroRNA Reverse Transcription Kit, TaqMan® Fast Universal PCR Master Mix (2x). RNU6B was used as reference miRNA. Quantity alterations of 20 microRNAs (hsa-miR-219, -203, -148a, -129, -9, -34a, -34b, -34c-3p, -127, -193a-5p, -191, -17, -24 -2 * , -339 -3p, -212, -375, -125b, -124a, -132, -137) were determined in samples of tumor compared to normal tissue biopsy from the kidney of each patient. It was shown that the expression of studied miRNAs usually decreased in RCC tumors. The largest decrease of expression was observed for miR-129, which expression was10–350-fold reduced in 93% of the samples ( P P
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
